1. Home
  2. CRGX vs NRGV Comparison

CRGX vs NRGV Comparison

Compare CRGX & NRGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • NRGV
  • Stock Information
  • Founded
  • CRGX 2021
  • NRGV 2017
  • Country
  • CRGX United States
  • NRGV United States
  • Employees
  • CRGX N/A
  • NRGV N/A
  • Industry
  • CRGX
  • NRGV Industrial Machinery/Components
  • Sector
  • CRGX
  • NRGV Miscellaneous
  • Exchange
  • CRGX Nasdaq
  • NRGV Nasdaq
  • Market Cap
  • CRGX 180.4M
  • NRGV 190.1M
  • IPO Year
  • CRGX 2023
  • NRGV N/A
  • Fundamental
  • Price
  • CRGX $4.07
  • NRGV $0.70
  • Analyst Decision
  • CRGX Hold
  • NRGV Hold
  • Analyst Count
  • CRGX 7
  • NRGV 5
  • Target Price
  • CRGX $4.67
  • NRGV $1.70
  • AVG Volume (30 Days)
  • CRGX 773.9K
  • NRGV 2.0M
  • Earning Date
  • CRGX 03-12-2025
  • NRGV 03-17-2025
  • Dividend Yield
  • CRGX N/A
  • NRGV N/A
  • EPS Growth
  • CRGX N/A
  • NRGV N/A
  • EPS
  • CRGX N/A
  • NRGV N/A
  • Revenue
  • CRGX N/A
  • NRGV $46,199,000.00
  • Revenue This Year
  • CRGX $119.08
  • NRGV $795.02
  • Revenue Next Year
  • CRGX N/A
  • NRGV $16.22
  • P/E Ratio
  • CRGX N/A
  • NRGV N/A
  • Revenue Growth
  • CRGX N/A
  • NRGV N/A
  • 52 Week Low
  • CRGX $3.00
  • NRGV $0.63
  • 52 Week High
  • CRGX $25.45
  • NRGV $2.70
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 40.37
  • NRGV 22.18
  • Support Level
  • CRGX $3.98
  • NRGV $0.79
  • Resistance Level
  • CRGX $4.25
  • NRGV $1.03
  • Average True Range (ATR)
  • CRGX 0.22
  • NRGV 0.12
  • MACD
  • CRGX 0.16
  • NRGV -0.02
  • Stochastic Oscillator
  • CRGX 36.84
  • NRGV 4.50

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About NRGV Energy Vault Holdings Inc.

Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.

Share on Social Networks: